Innocan Pharma posts Q2 FY2026 revenue of US$5.25M (CAD 7.3M)
Innocan Pharma reported second quarter fiscal year 2026 revenue of US$5.25M (CAD 7.3M).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.